Literature DB >> 20187750

Emergency department arrival times, treatment, and functional recovery in women with acute ischemic stroke.

Wesley Knauft1, Jyoti Chhabra, Louise D McCullough.   

Abstract

BACKGROUND: Sex disparities have been well documented in patients with ischemic stroke. Previous studies have suggested that female sex is a risk factor for delay in arrival time to the emergency department (ED) and may contribute to ineligibility for thrombolytic therapy. With the increase in education efforts targeting women, we investigated whether ED arrival times, rates of thrombolytic use, and functional outcomes continue to differ in men and women with acute ischemic stroke (AIS).
METHODS: This study was a retrospective database analysis of patients with AIS (2001-2008). All AIS patients presenting within 24 hours with a known time of symptom onset and a documented admission National Institutes of Health Stroke Scale (NIHSS) were included. The Modified Barthel Index (MBI) assessed patients' functional status preadmission (historical), admission, and at 3 and 12 months poststroke.
RESULTS: Included in the analysis were 480 (50.6%) women and 468 (49.4%) men. Women were significantly older than men (70.6 +/- 0.7 vs. 65.3 years +/- 0.6, p <or= 0.001). Mean onset-to-ED time was not significantly different between the sexes (women 265 +/- 283 vs. men 245 +/- 300 minutes), nor was prestroke MBI. Logistic regression analysis demonstrated that female sex, increasing age, higher admission NIHSS, and longer onset-to-ED times all contributed to poorer functional status.
CONCLUSIONS: Women arrive at the ED at equivalent speed as men after AIS. Women had greater functional impairments at 3 months and 12 months poststroke despite equivalent prestroke MBI and admission NIHSS. Female sex contributes to poorer chronic functional outcomes after AIS.

Entities:  

Mesh:

Year:  2010        PMID: 20187750      PMCID: PMC2940485          DOI: 10.1089/jwh.2009.1616

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  30 in total

1.  IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.

Authors:  Y Z Deng; M J Reeves; B S Jacobs; G L Birbeck; R U Kothari; S L Hickenbottom; A J Mullard; S Wehner; K Maddox; A Majid
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

2.  Gender comparisons of diagnostic evaluation for ischemic stroke patients.

Authors:  Melinda A Smith; Lynda D Lisabeth; Devin L Brown; Lewis B Morgenstern
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Patient behavior immediately after transient ischemic attack according to clinical characteristics, perception of the event, and predicted risk of stroke.

Authors:  Matthew F Giles; Enrico Flossman; Peter M Rothwell
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

4.  Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

Authors:  David M Kent; Lori Lyn Price; Peter Ringleb; Michael D Hill; Harry P Selker
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

5.  Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke.

Authors:  Sean I Savitz; Gottfried Schlaug; Louis Caplan; Magdy Selim
Journal:  Stroke       Date:  2005-06-09       Impact factor: 7.914

6.  Critical factors determining access to acute stroke care.

Authors:  S C Menon; D K Pandey; L B Morgenstern
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

Review 7.  A systematic review of delays in seeking medical attention after transient ischaemic attack.

Authors:  N Sprigg; C Machili; M E Otter; A Wilson; T G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-08       Impact factor: 10.154

8.  Tracking women's awareness of heart disease: an American Heart Association national study.

Authors:  Lori Mosca; Anjanette Ferris; Rosalind Fabunmi; Rose Marie Robertson
Journal:  Circulation       Date:  2004-02-04       Impact factor: 29.690

9.  Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke.

Authors:  Lori Mandelzweig; Uri Goldbourt; Valentina Boyko; David Tanne
Journal:  Stroke       Date:  2006-03-23       Impact factor: 7.914

10.  Sex and acute stroke presentation.

Authors:  Lise A Labiche; Wenyaw Chan; Kamaldeen R Saldin; Lewis B Morgenstern
Journal:  Ann Emerg Med       Date:  2002-11       Impact factor: 5.721

View more
  6 in total

Review 1.  Sexual dimorphism in ischemic stroke: lessons from the laboratory.

Authors:  Bharti Manwani; Louise D McCullough
Journal:  Womens Health (Lond)       Date:  2011-05

2.  Stroke in Women: What is Different?

Authors:  Dara G Jamieson; Maryna Skliut
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

3.  Sex differences in outcomes and risk factors among elderly patients with ischemic stroke.

Authors:  Chunying Zou; Chunjie Wei; Zengmian Wang; Yuling Jin
Journal:  Oncotarget       Date:  2017-10-19

Review 4.  If Time Is Brain Where Is the Improvement in Prehospital Time after Stroke?

Authors:  Jeremy N Pulvers; John D G Watson
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

5.  Rate and Determinants of Recurrence at 1 Year and 5 Years After Stroke in a Low-Income Population in Rural China.

Authors:  Jing Han; Wenjing Mao; Jingxian Ni; Yanan Wu; Jie Liu; Lingling Bai; Min Shi; Jun Tu; Xianjia Ning; Jinghua Wang
Journal:  Front Neurol       Date:  2020-01-23       Impact factor: 4.003

6.  Sex Differences in Stroke Subtypes, Severity, Risk Factors, and Outcomes among Elderly Patients with Acute Ischemic Stroke.

Authors:  Changshen Yu; Zhongping An; Wenjuan Zhao; Wanjun Wang; Chunlin Gao; Shoufeng Liu; Jinghua Wang; Jialing Wu
Journal:  Front Aging Neurosci       Date:  2015-09-08       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.